Isradipine EP Impurity E
| Catalog No. | KMI076006 |
|---|---|
| CAS No. | 2747938-19-6 |
| Formula | C26H23N5O6 |
| FW | 501.5 |
| Unit | Price | Stock |
|---|---|---|
| 100 mg | Enquire | Enquire |
| Chemical Name: | Mixture of 3-methyl 5-(propan-2-yl) (4RS)-4-(2,1,3-benzoxadiazol-4-yl)-2-[(1EZ)-2-(2,1,3-benzoxadiazol-4-yl)ethen-1-yl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate and 5-methyl 3-(propan-2-yl) (4RS)-4-(2,1,3-benzoxadiazol-4-yl)-2-[(1EZ)-2-(2,1,3-benzoxadiazol-4-yl)ethen-1-yl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate (as per EP) |
|---|---|
| Purity: | >95% |
| Storage: | Store at 2-8 deg. C for long term storage |
| Shipping: | Product is stable to be Shipped at Room Temperature |
Isradipine EP Impurity E is chemically Mixture of 3-methyl 5-(propan-2-yl) (4RS)-4-(2,1,3-benzoxadiazol-4-yl)-2-[(1EZ)-2-(2,1,3-benzoxadiazol-4-yl)ethen-1-yl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate and 5-methyl 3-(propan-2-yl) (4RS)-4-(2,1,3-benzoxadiazol-4-yl)-2-[(1EZ)-2-(2,1,3-benzoxadiazol-4-yl)ethen-1-yl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate (as per EP) .
Isradipine EP Impurity E is supplied with detailed characterization data compliant with regulatory guideline.
Isradipine EP Impurity E can be used for the analytical method development, method validation (AMV), Quality Controlled (QC)
application for Abbreviated New Drug Application (ANDA) or during commercial production of Isradipine EP Impurity E.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
Related Products
CAT No: KMI076001
CAT No: KMI076002
CAT No: KMI076003
CAT No: KMI076004
CAT No: KMI076005
CAT No: KMI076007